FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Ultra Seal Multi-Symptom Cramp Relief Recall

Multi-Symptom Cramp Relief (acetaminophen 325mg and Pamabrom 25mg), 2- tablet packets, Mfd

Ultra Seal Corporation · New Paltz, NY

Risk level
Class II
Reported by FDA
Feb 9, 2022
Recall ID
D-0481-2022
Check your lot numberHow we source this data

Summary

Ultra Seal recalled Multi-Symptom Cramp Relief starting Jan 24, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0481-2022 on Feb 9, 2022. Reason: cGMP deviations. Status: Terminated.

Why it was recalled

cGMP deviations

Product description

Multi-Symptom Cramp Relief (acetaminophen 325mg and Pamabrom 25mg), 2- tablet packets, Mfd. for First Aid Direct, Mason, OH 45040

Lot numbers, UPCs & expiration codes

Lot #: AK9453, Exp. Date 01/2022; AK9716, 07/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0481-2022
Classification
Class II
Status
Terminated
Recall initiated
Jan 24, 2022
FDA report date
Feb 9, 2022
Quantity
1,351,660 packets
Recall type
Voluntary: Firm initiated
Recalling firm
Ultra Seal Corporation

Original FDA data

Every field from FDA enforcement report D-0481-2022, exactly as published.

Show all FDA fields
City
New Paltz
State
NY
Status
Terminated
Country
United States
Event ID
89464
Address
521 Main St
Code information
Lot #: AK9453, Exp. Date 01/2022; AK9716, 07/2022
Postal code
12561-1609
Report date
Feb 9, 2022
Product type
Drugs
Recall number
D-0481-2022
Classification
Class II
Recalling firm
Ultra Seal Corporation
Product quantity
1,351,660 packets
Termination date
Oct 16, 2023
Reason for recall
cGMP deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Multi-Symptom Cramp Relief (acetaminophen 325mg and Pamabrom 25mg), 2- tablet packets, Mfd. for First Aid Direct, Mason, OH 45040
Distribution pattern
Nationwide within the United States
Recall initiation date
Jan 24, 2022
Initial firm notification
Letter
Center classification date
Jan 31, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0481-2022, published Feb 9, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls